Walgreens to begin selling over-the-counter COVID-19 rapid test
Table of Contents
Walgreens announced Monday that it will begin selling an over-the-counter COVID-19 rapid test this week at stores nationwide.
The Abbott BinaxNOW COVID-19 Self Test will be available for $23.99, according to Walgreens officials. It will be for sale in store, online and available by curbside pickup.
Customers can self-administer the test collection using a short nasal swab (not the deep and invasive nasopharyngeal swab, according to officiails) and check test results in 15 minutes. The BinaxNOW COVID-19 Self Test is the most studied rapid antigen in the U.S., having first been approved in the U.S. for professional use in August 2020.
“Even as vaccines become more widely available, COVID-19 testing remains a critical tool to keep our communities safe. The addition of this over-the-counter test in-store will help ensure our customers have access to testing solutions when and how they need it – at home or at one of our conveniently located testing sites,” said John Standley, president, Walgreens. “Working with Abbott and other partners, Walgreens now offers the most comprehensive suite of COVID-19 diagnostic testing options in America, helping encourage consistent, widespread testing.”
In addition, Walgreens is currently conducting in-store COVID testing at some 5,500 locations and will add another 500 or so by May.
